Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Quince Therapeutics, Inc. (QNCX) had Weighted-Average Shares Outstanding (Diluted) of 43.26M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-56.83M |
|
-- |
|
-- |
|
$57.28M |
|
$-57.28M |
|
$0.54M |
|
$-56.74M |
|
$-56.74M |
|
$-56.83M |
|
$-56.83M |
|
$-56.83M |
|
$-56.83M |
|
$-57.28M |
|
$-42.32M |
|
43.26M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
43.26M |
$-1.31 |
|
$-1.31 |
|
| Balance Sheet Financials | |
$44.04M |
|
$0.32M |
|
$70.44M |
|
$114.48M |
|
$7.28M |
|
$14.32M |
|
$77.05M |
|
$84.33M |
|
$30.15M |
|
$-29.90M |
|
$30.15M |
|
44.00M |
|
| Cash Flow Statement Financials | |
$-31.90M |
|
$21.91M |
|
$-4.78M |
|
$20.75M |
|
$6.21M |
|
$-14.54M |
|
$4.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.05 |
|
-- |
|
-- |
|
0.32 |
|
0.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-32.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-188.51% |
|
190.07% |
|
-49.64% |
|
-127.80% |
|
$0.69 |
|
$-0.74 |
|
$-0.74 |
|